Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes
Clinical trial NCT00437112 · COMPLETED
Trial details
- NCT number
- NCT00437112
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-05-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.